OpenSecrets' tally of federal lobbying by the pharmaceuticals/health-products industry: $391,572,500 in 2024 across 665 clients and 1,838 lobbyists, with PhRMA ($31.7M), Amgen ($11.8M), Merck ($9.2M) and Pfizer ($9.1M) the largest spenders.
$391,572,500
Annual lobbying totals, 2024
OpenSecrets' tally of federal lobbying by the pharmaceuticals/health-products industry: $391,572,500 in 2024 across 665 clients and 1,838 lobbyists, with PhRMA ($31.7M), Amgen ($11.8M), Merck ($9.2M) and Pfizer ($9.1M) the largest spenders. Compiled from Senate LDA filings (lda.gov) and FEC data released 6 February 2025; OpenSecrets is a non-profit, no industry funding disclosed on the page. It also reports 1,027 'revolvers' – 55.88% of lobbyists had prior government service. No product or comparator. Study type: other.
